RESULTS Absorption enhancer,protease inhibitors and liposomes have their potential to achieve substantial bioavailability of protein and peptide drugs from pulmonary administration.

• 结果吸收促进剂、酶抑制剂及脂质体均可使蛋白质及多肽类药物的肺部吸收明显提高,甚至达到治疗所需的生物利用度。